Results 231 to 240 of about 1,563,252 (400)
ABSTRACT Valve‐in‐valve (ViV) Transcatheter aortic valve replacement (TAVR) has emerged as a valid treatment option in symptomatic patients with failed aortic bioprosthetic valves, most especially in those with intermediate, high or prohibitive risk of surgery. Due to the unique design of stentless bioprosthetic valves with absence of visible posts and
Adeogo Akinwale Olusan+3 more
wiley +1 more source
Characterization of Coronary Artery Disease in Sepsis Survivors. [PDF]
Malomo S+12 more
europepmc +1 more source
Aetiology of coronary artery disease: an historical approach.
L. Michaels
openalex +1 more source
Genetics of coronary artery disease: discovery, biology and clinical translation
A. Khera, S. Kathiresan
semanticscholar +1 more source
ABSTRACT Background Plug‐based vascular closure devices (Pb‐VCD) and suture‐based vascular closure devices (Sb‐VCD) are used for percutaneous vascular access site closure during transcatheter aortic valve replacement (TAVR). Until now, no clear superiority of either device was shown in studies comparing 18 F VCDs solely.
Tobias Lerchner+6 more
wiley +1 more source
Prognosis in coronary artery disease. Angiographic, hemodynamic, and clinical factors. [PDF]
Gary W. Burggraf, J. O. Parker
openalex +1 more source
Coronary Artery Vasculopathy in a Cohort of Heart Transplant Recipients: A Single Center Experience
ABSTRACT Background Coronary allograft vasculopathy (CAV) is a significant cause of late mortality in heart transplant recipients. This study assesses the development of CAV, associated rejection rates, and the potential impact of percutaneous coronary intervention (PCI) on survival in a cohort of heart transplant patients.
Hussein Krayem+4 more
wiley +1 more source
Neuroprotective Strategies in Coronary Artery Disease Interventions. [PDF]
Fatima M+12 more
europepmc +1 more source
Aorta-to-Coronary-Artery Vein Bypass Graft for Coronary Artery Occlusive Disease
Harold C. Urschel+5 more
openalex +1 more source